James L. Cunniff - 08 Jun 2026 Form 4 Insider Report for Electromed, Inc. (ELMD)

Reporting relationship: CEO and President, Director
Issuer ticker: ELMD
Reported as of: 08 Jun 2026
Net transaction value: -$354,095
SEC form: 4
Accepted by SEC: 09 Jun 2026, 17:12:58 UTC
Prior SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Joshua L. Colburn, Attorney-in-Fact

Key filing fact

James L. Cunniff filed Form 4 for Electromed, Inc. (ELMD) on 09 Jun 2026.

Key facts

This page summarizes James L. Cunniff's Form 4 filing for Electromed, Inc. (ELMD).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2026, 17:12.

Change

Previous filing in this sequence was filed on 04 Sep 2025.
Current net transaction value: -$354,095.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001983687 Primary reporting owner

Cunniff James L.

Relationship: CEO and President, Director
Address: 500 SIXTH AVENUE NW, NEW PRAGUE
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Signature date: 09 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELMD transaction

Common Stock

Options Exercise

Transaction value
Shares: +9,700
Change %: +6.6%
Price: $17.25^*
Shares after: 157,451
Date: 08 Jun 2026
Ownership: Direct

ELMD transaction

Common Stock

Sale

Transaction value: $253,852
Shares: -7,003
Change %: -4.4%
Price: $36.25
Shares after: 150,448
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F1

ELMD transaction

Common Stock

Sale

Transaction value: $61,489
Shares: -1,671
Change %: -1.1%
Price: $36.80
Shares after: 148,777
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F2

ELMD transaction

Common Stock

Sale

Transaction value: $38,755
Shares: -1,026
Change %: -0.69%
Price: $37.77
Shares after: 147,751
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELMD transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -9,700
Change %: -33%
Price: $0.000000^*
Shares after: 19,400
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,700
Exercise price: $17.25
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the weighted average price of 7,003 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $35.61 to $36.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

Reflects the weighted average price of 1,671 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $36.62 to $37.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Reflects the weighted average price of 1,026 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 8, 2026 with sale prices ranging from $37.69 to $38.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

Options scheduled to vest and become exercisable in three equal annual installments on each of the first business days of September 2025, 2026 and 2027.